CCR4 in cutaneous T-cell lymphoma: therapeutic targeting of a pathogenic driver. Nicolay JP, Albrecht JD, Alberti-Violetti S, Berti E, et al. Eur J Immunol 2021 Apr 3. doi: 10.1002/eji.202049043.

Read + Share

Amedeo Smart

Independent Medical Education

Nicolay JP, Albrecht JD, Alberti-Violetti S, Berti E, et al. CCR4 in cutaneous T-cell lymphoma: therapeutic targeting of a pathogenic driver. Eur J Immunol 2021 Apr 3. doi: 10.1002/eji.202049043.
PMID: 33811642